Paper29680948
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER. World J Urol, 2018. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. Papers, record 29680948. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29680948
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Neoplastic Syndromes, Hereditary | Major topic |
| Age of Onset | |
| Birt-Hogg-Dube Syndrome | |
| Disease Management | |
| Early Detection of Cancer | |
| Fumarate Hydratase | |
| Humans | |
| Leiomyomatosis | |
| Neoplasms, Multiple Primary | |
| Proto-Oncogene Proteins | |
| Proto-Oncogene Proteins c-met | |
| Skin Neoplasms | |
| Succinate Dehydrogenase | |
| Tumor Suppressor Proteins | |
| Ubiquitin Thiolesterase | |
| Uterine Neoplasms | |
| Von Hippel-Lindau Tumor Suppressor Protein | |
| von Hippel-Lindau Disease |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Advanced Researcher Award | European Research Council | International | PubMed |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10353251 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. | Nature | 1999 | https://conductscience.org/library/papers/10353251 | PubMed |
| 2 | 10657297 | Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. | Science | 2000 | https://conductscience.org/library/papers/10657297 | PubMed |
| 3 | 10770180 | A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. | J Clin Endocrinol Metab | 2000 | https://conductscience.org/library/papers/10770180 | PubMed |
| 4 | 11404820 | Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. | Am J Hum Genet | 2001 | https://conductscience.org/library/papers/11404820 | PubMed |
| 5 | 11865300 | Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. | Nat Genet | 2002 | https://conductscience.org/library/papers/11865300 | PubMed |
| 6 | 12086860 | Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12086860 | PubMed |
| 7 | 12124175 | HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12124175 | PubMed |
| 8 | 12204536 | Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12204536 | PubMed |
| 9 | 12459621 | Renal tumors in the Birt-Hogg-Dubé syndrome. | Am J Surg Pathol | 2002 | https://conductscience.org/library/papers/12459621 | PubMed |
| 10 | 12772087 | Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. | Am J Hum Genet | 2003 | https://conductscience.org/library/papers/12772087 | PubMed |
| 11 | 15201738 | The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. | J Urol | 2004 | https://conductscience.org/library/papers/15201738 | PubMed |
| 12 | 17024664 | Genotype-phenotype correlations in von Hippel-Lindau disease. | Hum Mutat | 2007 | https://conductscience.org/library/papers/17024664 | PubMed |
| 13 | 18728283 | Germline SDHB mutations and familial renal cell carcinoma. | J Natl Cancer Inst | 2008 | https://conductscience.org/library/papers/18728283 | PubMed |
| 14 | 18794106 | Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18794106 | PubMed |
| 15 | 1895313 | Von Hippel-Lindau disease: a genetic study. | J Med Genet | 1991 | https://conductscience.org/library/papers/1895313 | PubMed |
| 16 | 19234517 | The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. | Oncogene | 2009 | https://conductscience.org/library/papers/19234517 | PubMed |
| 17 | 19827124 | Population-based survey of cancer risks in chromosome 3 translocation carriers. | Genes Chromosomes Cancer | 2010 | https://conductscience.org/library/papers/19827124 | PubMed |
| 18 | 19850877 | Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19850877 | PubMed |
| 19 | 19959076 | Birt-Hogg-Dubé syndrome: diagnosis and management. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19959076 | PubMed |
| 20 | 21173220 | Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21173220 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42729084 | Prognostic value of systemic immune-inflammation index in patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42729084 | PubMed |
| 42494599 | Case Report: Fatal convergence of two confirmed and one radiologically suspected synchronous urological malignancies in a young patient: ultra-late clear cell renal cell carcinoma recurrence, contralateral renal tumor, and metastatic prostate cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42494599 | PubMed |
| 41935327 | Unveiling the epigenetic landscape: transforming renal cell carcinoma treatment. | Clin Epigenetics | 2026 | https://conductscience.org/library/papers/41935327 | PubMed |
| 41922306 | Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41922306 | PubMed |
| 41507604 | Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteria. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/41507604 | PubMed |
| 41280159 | Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know? | Eur Urol Open Sci | 2025 | https://conductscience.org/library/papers/41280159 | PubMed |
| 41063965 | Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41063965 | PubMed |
| 40952492 | Characterization of complex renal cysts in hereditary leiomyomatosis and renal cell cancerUsing magnetic resonance based qualitative features. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/40952492 | PubMed |
| 40806892 | Decoding Treatment Failures in Metastatic Renal Cell Carcinoma: Predictors Across Immunotherapy and Targeted Therapies from a Retrospective Real-World Analysis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40806892 | PubMed |
| 40098178 | Liver metastasis from a chromophobe renal cell carcinoma 18 years after initial diagnosis: a case report. | J Med Case Rep | 2025 | https://conductscience.org/library/papers/40098178 | PubMed |
| 39990653 | Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/39990653 | PubMed |
| 39896049 | Identifying Hereditary Leiomyomatosis and Renal Cell Cancer through Unobtrusive Cutaneous Nodules: A Clinical Report. | J Kidney Cancer VHL | 2025 | https://conductscience.org/library/papers/39896049 | PubMed |
| 39507957 | [Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: Clinicopathological Analysis of 11 Cases]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/39507957 | PubMed |
| 39369320 | Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation. | J Investig Med High Impact Case Rep | 2024 | https://conductscience.org/library/papers/39369320 | PubMed |
| 39339165 | Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339165 | PubMed |
| 39210603 | CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma. | Kaohsiung J Med Sci | 2024 | https://conductscience.org/library/papers/39210603 | PubMed |
| 39201746 | Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201746 | PubMed |
| 39085584 | ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome. | Eur J Hum Genet | 2024 | https://conductscience.org/library/papers/39085584 | PubMed |
| 38666938 | In Silico and In Vitro Study of Isoquercitrin against Kidney Cancer and Inflammation by Triggering Potential Gene Targets. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38666938 | PubMed |
| 38456787 | The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations. | Radiol Imaging Cancer | 2024 | https://conductscience.org/library/papers/38456787 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29680948
GET https://conductscience.org/api/papers/v1/29680948/references?page=2